Cargando…

MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2

MicroRNA-630 (miR-630) plays dual roles in tumor progression in various human cancers. However, the role of miR-630 in chemoresistance and prognosis in non-small cell lung cancer (NSCLC) remains to be elucidated. This retrospective study enrolled 114 surgically resected patients with NSCLC who exper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ming-Jenn, Wu, De-Wei, Wang, Gao-Chang, Wang, Yao-Chen, Chen, Chi-Yi, Lee, Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862613/ https://www.ncbi.nlm.nih.gov/pubmed/29568392 http://dx.doi.org/10.18632/oncotarget.24474

Ejemplares similares

A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
por: Wu, De-Wei, et al.
Publicado: (2018)

Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2
por: Tung, Min-Che, et al.
Publicado: (2016)

MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma
por: Chen, Wei-xun, et al.
Publicado: (2016)

Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival
por: Chu, Dake, et al.
Publicado: (2014)

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016)

MicroRNA 630 Represses NANOG Expression through Transcriptional and Post-Transcriptional Regulation in Human Embryonal Carcinoma Cells
por: Chu, Wing-Keung, et al.
Publicado: (2021)

PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness
por: Chen, Ming-Jenn, et al.
Publicado: (2016)

Corrigendum: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness
por: Chen, Ming-Jenn, et al.
Publicado: (2016)

Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness
por: Chen, Ming-Jenn, et al.
Publicado: (2020)

Conference - How to leave with less water ?- 26/04 - 6.30pm
por: Staff Association
Publicado: (2023)

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients
por: Yue, Taohua, et al.
Publicado: (2022)

MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
por: Zhang, Xin, et al.
Publicado: (2015)

microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy
por: Liu, Chan, et al.
Publicado: (2020)

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2017)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

MiR‐630 suppresses non‐small cell lung cancer by targeting vimentin
por: Wang, Bin, et al.
Publicado: (2022)

Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
por: Tang, Zhaopeng, et al.
Publicado: (2021)

Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
por: Leisching, Gina, et al.
Publicado: (2015)

Informationspflicht und Traumaverarbeitung: BGB 278, 280 Abs. 1, 630a Abs. 1, 630c Abs. 2 S. 2, 630h Abs. 5 S. 1
Publicado: (2022)

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
por: Ning, Fang-ling, et al.
Publicado: (2014)

An Exceptionally Favorable Response to Etoposide and Cisplatin
por: Valecha, Gautam, et al.
Publicado: (2015)

MiR-630 suppresses breast cancer progression by targeting metadherin
por: Zhou, Ci-Xiang, et al.
Publicado: (2015)

MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020)

Absence of p53 Overexpression and Favorable Response to Cisplatin‐based Neoadjuvant Chemotherapy in Urothelial Carcinomas
por: Kakehi, Yoshiyuki, et al.
Publicado: (1998)

MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
por: Chen, Xin, et al.
Publicado: (2019)

Sperm microRNAs confer depression susceptibility to offspring
por: Wang, Yanbo, et al.
Publicado: (2021)

MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells
por: Wang, Hongjiang, et al.
Publicado: (2015)

Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
por: Chen, Bo, et al.
Publicado: (2019)

Circular RNA MTO1 intercorrelates with microRNA‐630, both associate with Enneking stage and/or pathological fracture as well as prognosis in osteosarcoma patients
por: Shi, Zhihua, et al.
Publicado: (2021)

Inhibition of microRNA-665 Alleviates Septic Acute Kidney Injury by Targeting Bcl-2
por: Qi, Yongjie, et al.
Publicado: (2022)

Einwilligungszuständigkeit Minderjähriger bei Durchführung einer Coronaschutzimpfung: BGB 630a, 630d, 1626, 1628, 1697a
Publicado: (2022)

MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression
por: Huang, Jia-Yuan, et al.
Publicado: (2013)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum‐based chemotherapy in non‐small cell lung cancer
por: Chen, Ming‐Jenn, et al.
Publicado: (2020)

Human Papillomavirus Oncoproteins Confer Sensitivity to Cisplatin by Interfering with Epidermal Growth Factor Receptor Nuclear Trafficking Related to More Favorable Clinical Survival Outcomes in Non-Small Cell Lung Cancer
por: Wang, Jinn-Li, et al.
Publicado: (2022)

miR-630 functions as a tumor oncogene in renal cell carcinoma
por: Zhao, Jian-Jun, et al.
Publicado: (2016)

MicroRNA-29a enhances cisplatin sensitivity in non-small cell lung cancer through the regulation of REV3L
por: Chen, Xialin, et al.
Publicado: (2019)

Cyclic stretching boosts microRNA‐499 to regulate Bcl‐2 via microRNA‐208a in atrial fibroblasts
por: Chua, Su‐Kiat, et al.
Publicado: (2021)

MicroRNA-608 sensitizes non-small cell lung cancer cells to cisplatin by targeting TEAD2
por: Wang, Yanli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_joo7go9un5aj853ukbo83ngvuc